GGrantIndex
Sort

166,118 grants matching stem cells

Combinatorial Regulation of Gene Networks During Cardiac Development and Disease

$2,731,995
Deepak Srivastava · J. David Gladstone Institutes · P01 · FY2021 · HL

Combinatorial Regulation of Gene Networks During Cardiac Development and Disease

$2,731,195
Deepak Srivastava · J. David Gladstone Institutes · P01 · FY2020 · HL

Plasticity circuits in Alzheimer s disease

$2,730,368
Orly Lazarov · University Of Illinois At Chicago · RF1 · FY2020 · AG

Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets

$2,728,790
Philip L De Jager · Columbia University Health Sciences · U01 · FY2022 · AG

Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders

$2,728,503
Mitchell J Weiss · St. Jude Children'S Research Hospital · P01 · FY2021 · HL

Dnmt3a as an epigenetic target for chronic pain treatment

$2,728,155
Zhizhong Z Pan · University Of Tx Md Anderson Can Ctr · RF1 · FY2019 · NS

Genes and signals controlling mammalian hematopoiesis.

$2,727,753
Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD

Molecular Biology of Mammalian Gametogenesis, Fertilization and Early Development

$2,727,469
Jurrien Dean · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

Phage/Salmonella interactions during oxidative stress

$2,727,148
Andres Vazquez-Torres · University Of Colorado Denver · R01 · FY2025 · AI

Helping to End Addiction Long-term (HEAL): Induced Pluripotent Stem Cell (iPSC)-Derived Cell Types for Pain, Addiction and Overdose

$2,726,004
Ilyas Singec · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR

Genetic Analysis of Resistance to Viral Infection

$2,725,363
Bruce A Beutler · Ut Southwestern Medical Center · P01 · FY2012 · AI

PATHOPHYSIOLOGY OF THE ENDOTHELIUM

$2,724,744
Brigham And Women'S Hospital · P01 · FY2001 · HL

Clinical Investigations On The Etiology And Therapy Of Neurogenetic Disorders

$2,724,142
Henry F McFarland · Neurological Disorders And Stroke · Z01 · FY2007 · NS

Combinatorial Regulation of Gene Networks During Cardiac Development and Disease

$2,723,920
Deepak Srivastava · J. David Gladstone Institutes · P01 · FY2023 · HL

Combinatorial Regulation of Gene Networks During Cardiac Development and Disease

$2,723,920
Deepak Srivastava · J. David Gladstone Institutes · P01 · FY2022 · HL

Reactive Oxygen Species, Stem cells and Aging

$2,723,235
Toren Finkel · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL

Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders

$2,722,946
Mitchell J Weiss · St. Jude Children'S Research Hospital · P01 · FY2022 · HL

The Molecular Biology Of The Mammalian Brain

$2,719,917
Ronald McKay · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS

Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders

$2,719,866
Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL

CENTER OF EXCELLENCE IN DIABETES AND OBESITY RESEARCH

$2,716,871
Aruni Bhatnagar Bhatnagar · University Of Louisville · P20 · FY2008 · RR

Center of Excellence in Diabetes and Obesity Research

$2,716,871
Aruni Bhatnagar Bhatnagar · University Of Louisville · P20 · FY2008 · RR

Mechanism Of Action And Functions Of The Gli-related Proteins Glis 1-3

$2,716,868
Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES

Stem Cell-Engineered Tumor Immunity in Man

$2,716,765
David Baltimore · California Institute Of Technology · P01 · FY2013 · CA

THERAPY OF CML

$2,715,148
University Of Texas Md Anderson Can Ctr · P01 · FY2001 · CA

Genetic analysis of type II diabetes in Finnish population

$2,715,021
Francis Sellers Collins · National Human Genome Research Institute · ZIA · FY2018 · HG